Schering-Plough Announces FDA Approval Of PEGINTRON(TM) And REBETOL(R) Combination Therapy For Treating Pediatric ... (Medical News Today)
First and only approved peginterferon in combination with ribavirin for previously untreated children with chronic hepatitis C addresses unmet medical need Schering-Plough Corporation (NYSE: SGP) today announced that the U.S.

FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough Vaccine, BOOSTRIX(R), For Adults (Medical News Today)
GlaxoSmithKline (NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved BOOSTRIX(R) [Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine, Adsorbed (Tdap)] for use in adults 19-64 years of age.